Dr. Laszlo Z. Galffy, MD

Dr. Galffy practices at Adventist Health Glendale in Glendale, California, part of Adventist Health.

Dr. Galffy's NPI, 1659398568, was assigned on July 16, 2006. Dr. Galffy graduated from Carol Davila University of Medicine and Pharmacy in 1973. Dr. Galffy holds California license A53830.

Dr. Galffy's primary practice is Adventist Health Glendale, at 1509 E Wilson Terrace, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 409-8202.

Dr. Galffy's primary practice is Adventist Health Glendale in Glendale, California, part of Adventist Health. The medical group on file is Adventist Health Glendale. Dmand AI also links Dr. Galffy to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Galffy's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galffy practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Galffy's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Galffy is board certified in anesthesiology by the American Board of Anesthesiology. Dr. Galffy is licensed in California.

Dmand AI lists lower back pain among the conditions Dr. Galffy treats.

CMS data shows 15 Medicare services from Dr. Galffy across 1 procedure code in 2023, for 80 Medicare patients. Medicare paid $2,180 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Galffy in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have arthritis, and 75% have high blood pressure. 81% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galffy's median patient age at 60, with 63% women.

In 2024, Dr. Galffy wrote 66 Medicare Part D claims. 97% of them were for generic drugs. CMS names the drug for 47 of them, across 4 drugs with 11 or more claims each, at $602 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Galffy for performance year 2024, reported as part of a group. Dr. Galffy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Galffy from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $149.

Dr. Galffy graduated from Carol Davila University of Medicine and Pharmacy in 1973.

Dr. Galffy is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.